ARGX-118

ARGX-118 was designed as a highly differentiated antibody against Galectin-10, the protein of Charcot-Leyden crystals (CLCs), which are implicated as a major contributor to airway inflammation and to the persistence of mucus plugs.

Key: IV: Intravenous
SC: Subcutaneous
+ AZA: Azacitidine
+VEN: Venetoclax
Neuromuscular
Hematology
Dermatology
Nephrology
Program
Clinical trial

Pipeline

ARGX-118

Target
Galectin-10
Preclinical
Phase 1
Phase 2
Phase 3
Registration
Commercial
Airway Inflammation

Potential in severe airway inflammation indications